Scarica l'app Stockscreener
1.61
6.62%
0.10
Precedente Chiudi:
$1.51
Aprire:
$1.51
Volume 24 ore:
3.14M
Relative Volume:
1.67
Capitalizzazione di mercato:
$599.34M
Reddito:
$106.34M
Utile/perdita netta:
$-74.66M
Rapporto P/E:
-1.5189
EPS:
-1.06
Flusso di cassa netto:
$-46.12M
1 W Prestazione:
-12.50%
1M Prestazione:
-15.26%
6M Prestazione:
-37.60%
1 anno Prestazione:
-29.07%
Intervallo 1D:
$1.475
$1.69
Intervallo di 1 settimana:
$1.46
$1.84
Portata 52W:
$1.21
$3.04
Standard Biotools Inc Stock (LAB) Company Profile
Nome
Standard Biotools Inc
Settore
Industria
Telefono
(650) 266-6000
Indirizzo
2 TOWER PLACE, SOUTH SAN FRANCISCO
Confronta LAB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| LAB | 1.61 | 599.34M | 106.34M | -74.66M | -46.12M | -1.06 |
| ABT | 115.93 | 201.34B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 385.68 | 146.32B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.17 | 132.22B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 84.11 | 107.39B | 33.00B | 4.29B | 5.50B | 2.71 |
| EW | 69.54 | 41.01B | 6.60B | 4.16B | 490.10M | 2.34 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-07-12 | Iniziato | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Borsa (LAB) Ultime notizie
Sumitomo Mitsui Trust Group Inc. Decreases Holdings in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Indaba Capital Management L.P. Acquires New Stake in Standard Bi - GuruFocus.com
Creative Planning Purchases Shares of 20,328 Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools names new CFO By Investing.com - Investing.com Australia
ARK Investment Management LLC Lowers Stock Holdings in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Standard BioTools (STU:FLB) Price-to-Operating-Cash-Flow : (As of Nov. 07, 2024) - GuruFocus.com
Standard BioTools (STU:FLB) Revenue per Share : €0.67 (TTM As of Sep. 2024) - GuruFocus.com
Standard BioTools appoints Kim as Chief Financial Officer - TipRanks
Standard BioTools names new CFO - Investing.com
Standard BioTools Names Alex Kim as New CFO - TipRanks
Standard BioTools Appoints Alex Kim as Chief Financial Officer - GlobeNewswire
Standard BioTools Names Co-Founder Alex Kim as CFO, Brings 30-Year Industry Expertise | LAB Stock News - StockTitan
Form 10-Q STANDARD BIOTOOLS INC. For: Sep 30 - StreetInsider.com
Vanguard Group Inc's Strategic Acquisition in Standard BioTools Inc - GuruFocus.com
Earnings Release: Here's Why Analysts Cut Their Standard BioTools Inc. (NASDAQ:LAB) Price Target To US$3.17 - Yahoo Finance
TD Cowen trims Standard BioTools target, sees upside in margins and SomaScan performance - Investing.com Australia
Standard BioTools Q3 2024 Earnings Preview - MSN
Standard BioTools Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St
Earnings call: Standard BioTools faces mixed Q3 results amid market challenges - Investing.com Australia
Standard BioTools Inc (LAB) Q3 2024 Earnings Call Highlights: Navigating Market Challenges with ... - Yahoo Finance
Standard BioTools Inc (LAB) Q3 2024 Earnings Call Highlights: Navigating Market Challenges with ... By GuruFocus - Investing.com Canada
Standard BioTools Inc. (NASDAQ:LAB) Q3 2024 Earnings Call Transcript - Insider Monkey
Standard BioTools price target lowered to $2.50 from $2.75 at TD Cowen - TipRanks
Standard BioTools to Participate in Upcoming Investor Conferences - The Manila Times
Standard Biotools earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Standard BioTools Inc. Reports Q3 2024 Financial Performance - TipRanks
Standard BioTools: Q3 Earnings Snapshot - mySA
Standard BioTools reports Q3 EPS (7c), consensus (9c) - TipRanks
Standard BioTools (LAB) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Standard BioTools Reports Strong Q3 2024 Performance - TipRanks
Standard BioTools, SomaLogic fall after shareholder nod for merger - MSN
Standard BioTools Reports Third Quarter 2024 Financial Results - The Manila Times
Standard BioTools Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Standard BioTools (NASDAQ:LAB) Trading 5.9% HigherShould You Buy? - MarketBeat
Standard BioTools And 2 Other Penny Stocks Executives Are Buying - MSN
Standard BioTools (NASDAQ:LAB) Has Debt But No Earnings; Should You Worry? - Simply Wall St
Standard BioTools (LAB) to Release Earnings on Wednesday - MarketBeat
Millennium Management LLC Acquires Shares in Standard BioTools I - GuruFocus.com
Millennium Management LLC Acquires Shares in Standard BioTools Inc - Yahoo Finance
LABStandard BioTools Inc. Latest Stock News & Market Updates - StockTitan
Standard BioTools Announces Conference Call and Webcast for - GlobeNewswire
Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024 - StockTitan
Get in on Standard BioTools Inc’s (LAB) buy-in window today! - SETE News
Financial Analysis: Standard BioTools Inc (LAB)’s Ratios Unveil Key Insights - The Dwinnex
A Guide To The Risks Of Investing In Standard BioTools Inc (LAB) - Knox Daily
Standard BioTools (NASDAQ:LAB) Trading Down 4%Time to Sell? - MarketBeat
Can you now get a good deal on Standard BioTools Inc’s shares? - US Post News
Dimensional Fund Advisors LP Sells 904,474 Shares of Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Standard Biotools Inc Azioni (LAB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.12%
1.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):